The Radioconjugates Strategy & Delivery Head supports end-to-end delivery of this new therapeutic modality from discovery to commercialization.
Base: $246,069.60 - $369,104.40; Bonus/Equity: Short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: Qualified retirement program (401(k) plan), paid vacation and holidays, paid leaves, health benefits (medical, prescription drug, dental, vision)
Must-have
Nice-to-have
Not specified